The GLP is committed to full transparency. Download and review our 2019 Annual Report

On the verge of stem cell “cure” for macular degeneration

The GLP curated this excerpt as part of a daily selection of biotechnology-related news, opinion and analysis.

Sufferers of an incurable form of a common age-related eye disease that leads to blindness could soon be cured, thanks to ground-breaking stem cell research.

Developmental biologist and Nobel laureate Professor John Gurdon says that stem cell replacement therapy for the dry form of macular degeneration has been shown to “work quite well” in animals and is now being tested in humans.

Speaking in Hong Kong, the 80-year-old Gurdon said: “My understanding is that the permission to offer this as a therapeutic treatment is about six months away. The trials in humans take about three months to see if they’re successful, and then after that it should really be no problem in making [the treatment] available to patients.”

Read the full, original story: Stem cell researchers on brink of cure for macular degeneration

News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend